Diakonhjemmet Hospital
Oslo, 0319, Norway
NCT Number: NCT04084834
In this project, a web-based exercise program is developed in co-creation between specialized health care, the Norwegian Association for Rheumatic diseases (NRF) and a group of experienced patient representatives. The project emerges from the evidence that exercise is recommended as first-line treatment for patients with chronic diseases like hip- and knee-osteoarthritis (OA). However, the number of patients in need of targeted exercise will increase considerably the next decades, and their treatment needs cannot be fully handled within the health care system. Development of innovative and effective treatment trajectories and follow-up strategies is urgently required. Peer-support is recognized as an effective way to increase patients' long-term adherence to exercise. Thus, patient-organizations may be an unutilized resource in support and follow-up of patients who need long-term exercise as part of their treatment plan. After discharge from examination in hospital, patients with hip/knee OA will be recruited to follow-up in a novel web-based, peer-supported exercise program, and the feasibility of the intervention will be evaluated.
Looking for future studies?
Notify Me40 year–80 year
All sexes
Interventional
Not applicable
Oslo, 0319, Norway
The study will be conducted as a pre-post single-arm feasibility study comprising 50 participants.
The main objective of the study will be to evaluate the feasibility of the web-based, peer-supported exercise intervention in patients with hip and/or knee OA.
Specific research objectives are:
In the feasibility study, all participants will be allocated to an intervention group, receiving a 12-week web-based, peer-supported aerobic exercise program including weekly motivational messages. Patients between 40 and 80 years of age that are not candidates for surgery will be recruited from Diakonhjemmet Hospital, Oslo, Norway.
To assess and evaluate feasibility, we will report on descriptive statistics. Responsiveness will be assessed using Receiver Operating Curve (ROC) analyses.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be offered to take part in a 5-hour Learning and Mastery-course at Diakonhjemmet Hospital, receiving information about the osteoarthritis disease, symptoms and the importance of exercise and physical activity. Participants will then be given a weekly web-based exercise program (12 weeks) consisting of three aerobic exercise sessions per week. The exercise program consists of five levels, and the participants will each week be guided to the most appropriate level based on their measured physical fitness level and the weekly exercise diary. The participants will at initial assessment at Diakonhjemmet Hospital be instructed to use Borgs scale to adjust exercise level. Based on the weekly exercise diary the participants will also get motivational messages by email.
Time frame: baseline to 12 weeks
Time (hours/minutes) per participant-peer-support contact (frequency of contacts divided by total time used by peer-supporters).
Time frame: baseline to 12 weeks
Time (hours/minutes) per week per participant used on web-based exercise program delivery.
Time frame: baseline to 12 weeks
Time (hours/minutes) per week per participant used on motivational message delivery.
Time frame: baseline to 12 weeks
Proportion of received exercise diaries (0-12 per participant).
Time frame: baseline
Proportion of participants providing activity monitor data (at least 4 days, including one weekend day, with minimum 10 hours recording per day) at baseline.
Time frame: baseline
Proportion of participants completing the indirect maximal cardiorespiratory exercise test according to test-protocol at baseline.
Time frame: baseline
Proportion of potentially eligible participants approached that are invited.
Time frame: baseline
Proportion of eligible patients enrolled.
Time frame: baseline and 12 weeks
Proportion of enrolled participants providing data at 12 week post-test.
Time frame: 12 weeks
Total number of adverse events (by cause if possible) evaluated by answers at post-test: The four questions addressing possible adverse events: 1) Have you carried out any type of treatment during the last 3 months? (With treatment we mean medication, physical exercise, self-management course or any alternative treatments) (yes/no), 2) If yes, have you experienced any adverse event as a result of the treatment? (yes/no). 3) If yes, which adverse events as a result of treatment? 4) In your opinion, which treatment(s) do you think the adverse event was/were caused by? (medication, physical exercise, self-management course, alternative treatments, other) (Elaborate).
Time frame: baseline and 12 weeks
Assessed by accelerometer (ActiGraph GT3X+): Change in physical activity level measured as counts per minute (CPM), which is the total number of registered counts for all valid days divided by wear time. Thresholds for CPM will be used in calculation of time (minutes per week/day) spent on sitting (<100 CPM), and on light (100-2019 CPM), moderate-(>2019-5998 CPM) and vigorous (>5998) intensity physical activity.
Time frame: baseline and 12 weeks
Change in VO2 peak measured by indirect maximal cardiorespiratory exercise test (modified Balke-protocol). The indirect estimation of VO2 peak by prediction equations is based on incline, grade and speed at end stage, weight and age.
Time frame: baseline and 12 weeks
Change in the last week disability on five subscales; pain (10 items, scale 0-40), symptoms (5 items, scale 0-20), function in daily living (17 items, scale 0-68), function in sport and recreation (4 items, scale 0-16) and quality of life (4 items, scale 0-16). Items are scored by a five-point Likert scale ranging from 0 (least severe) to 4 (most severe). Total sum-score and subscale sum-scores will be converted to normalized scores ranging from 0 (extreme disability) to 100 (no disability).
Time frame: baseline and 12 weeks
Change in the last week disability on five subscales; pain (9 items, scale 0-36), symptoms (7 items, scale 0-28), function in daily living (17 items, scale 0-68), function in sport and recreation (5 items, scale 0-20) and quality of life (4 items, scale 0-16). Items are scored by a five-point Likert scale ranging from 0 (least severe) to 4 (most severe). Total sum-score and subscale sum-scores will be converted to normalized scores ranging from 0 (extreme disability) to 100 (no disability).
Time frame: baseline and 12 weeks
Patients will address one to three activities they have problems performing due to osteoarthritis. The degree of difficulty with performing these activities is rated from 0 (cannot perform the activity) to 10 (no problems).
Time frame: baseline and 12 weeks
Measured by The International Physical Activity Questionnaire-Short Form: Change in time (minutes per week/day) and Metabolic Equivalent of Task (MET-minutes per week/day) spent on sitting, walking, and moderate- and vigorous intensity physical activity the last week (0-7 days). METs are calculated by using the corresponding MET-values for walking (3.3 MET), and moderate-(4.0 MET) and vigorous (8.0 MET) intensity physical activity.
Time frame: baseline and 12 weeks
Measured by the three questions from the Nord-Trøndelag Health study (HUNT): change in average frequency (never/<1 per week/1 per week/2-3 per week/almost every day), intensity (easy without losing my breath or breaking into a sweat/so hard that I lose my breath and break into a sweat/I push myself to near-exhaustion) and duration (less than 15 minutes/15-29 minutes/30 minutes to 1 hour/more than 1 hour) of physical activity.
Time frame: baseline and 12 weeks
Measured by numeric rating scale ranging from 0 (no pain) to 10 (worst pain).
Time frame: baseline and 12 weeks
Measured by numeric rating scale ranging from 0 (no fatigue) to 10 (worst fatigue).
Time frame: baseline and 12 weeks
Measured by numeric rating scale ranging from 0 (good, no symptoms) to 10 (very bad, much symptoms).
Time frame: baseline and 12 weeks
EQ-5D-5L will be used for measuring health-related quality of life (www.euroqol.org): comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five levels of answers (no problems, slight problems, moderate problems, severe problems, and extreme problems). The average score on each dimension will be reported, and the total score can be calculated into an index value ranging from -0.59 to 1, where -0.59 represents worst possible state and 1 represents perfect health.
Time frame: baseline and 12 weeks
Measured by Arthritis Self-Efficacy Scale (ASES): comprises 11 items addressing pain and symptoms (scored on a 5-point scale ranging from not confident at all to very confident). The scores are summed up to a 0-100 score where higher score indicate better self-efficacy.
Time frame: baseline and 12 weeks
Measured by Exercise Beliefs and Exercise Habits questionnaire: comprises 20 items addressing exercise self-efficacy (4 items), barriers to exercise (3 items), benefits of exercise (5 items), and impact of exercise on arthritis (8 items), scored on a 5-point Likert scale ranging from strongly disagree to strongly agree. The scores on each subscale is summed up where higher scores indicate better self-efficacy.
Time frame: baseline to 12 weeks
Proportion of enrolled participants attending a 5-hour osteoarthritis learning and mastery-course (attendance registered by yes/no).
Time frame: baseline to 12 weeks
Total number of exercise sessions.
Time frame: baseline to 12 weeks
Average number of exercise sessions per week.
Time frame: baseline to 12 weeks
Total number of weeks with minimum one exercise session.
Time frame: baseline to 12 weeks
Total number of exercise sessions completed according to prescribed duration. Measured by a question about completion of the prescribed exercise-session (yes/no).
Time frame: baseline to 12 weeks
Total number of exercise sessions completed according to prescribed intensity. Measured by self-reported Rating of Perceived Exertion Scale (Borg RPE) ranging from 6 (resting) to 20 (maximal intensity).
Time frame: baseline
Registered by self-report: 1) frequency (number of consultations the last 6 months) with a general practitioner and specialist health care (rheumatologist, orthopedist, neurologist, other), 2) referred (yes/no, the last 6 months) to x-ray, magnetic resonance imaging, physiotherapist, healthy life center, occupational therapist, 3) frequency (number of consultations during the last 6 months) with a physiotherapist, manual therapist, chiropractor, alternative treatment, other due, 4) had a stay at a rehabilitation institution during the last 6 months (yes/no and number of days). Descriptive data will be reported.
Time frame: baseline
Registered by self-report: Frequency (never/<1 per month/monthly/weekly/daily/several times per day) of medication use (addressing pain, sleeping, depression, anxiety) the last 3 months will be self-reported through type, name and dosage (mg) of medication, in addition to use of other medication (yes/no) and type. Descriptive data will be reported.
Time frame: 12 weeks
Change in osteoarthritis pain (from baseline to post-test) measured by a 7-point Global Rating of Change scale ranging from -3 (much worse) to +3 (much better).
Diakonhjemmet Hospital
Other
Acronym: AktiWeb
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04645732
Arthritis, Behavior
Holbæk, Denmark
View Trial DetailsNCT05316194
Arthritis, Behavior
Malmö, Sweden
View Trial DetailsNCT03354091
Arthritis, Behavior
Dalby, Sweden
View Trial DetailsNCT04049318
Arthritis, Behavior
Malmö, Sweden
View Trial Details